|
Scheiße, war am Abend verhindert und nun seh ich das Ergebnis! Völlig überzogene Reaktion der Kleinanleger. Der Kurs wird sich auf diesem geringen Niveau stabilisieren und dann wieder steigen. Die News sind natürlich unerwartet negativ - hätte eher mit einer Pleite gerechnet, als mit so etwas. Positiv ist aber die Mitteilung des CEO. Denke, am Montag wird es eine kräftige Gegenbewegung geben. WESTLAKE VILLAGE, Calif., Jan. 9, 2004 (PRIMEZONE) -- QT 5, Inc. (OTC BB:QTFV.OB - News), manufacturer, distributor and marketers of biomedical products, today announced that it was unsuccessful in retaining the rights to United States Patent No. 6,268,386. In an arbitration proceeding brought by the Company, it was determined that QT 5, Inc. forfeited the existing patent assignment agreement by failing to achieve certain benchmarks within an initial time frame after the FDA prohibited the sale of NICOWater(tm) as a dietary supplement. ``This is obviously not the announcement we wanted to make regarding the outcome of this arbitration,`` said QT 5, Inc. President Steven H. Reder. ``The Company intends to assist the new owners with an orderly transfer of the patent.`` QT5, Inc. will cease the promotion and sale of the product under its name and trademark. Mr. Reder added, ``The good news is that our management team has been working to accelerate the introduction of our patented `Target System Diagnostics` product line. We have no plans to downsize our current staff and we are working very closely with our vendors and customers to make this transition as efficient as possible.`` QT 5, Inc. CEO, Timothy J. Owens noted, ``While we still believe there is a growing demand for products like NICOWater(tm), the long-term potential of QT 5 has always been vested in becoming a diagnostics and Bio-defense product provider. Our first major product that will be ready for governmental, commercial and institutional markets, is a five panel, self-contained, self regulating Drugs of Abuse Test cup. Designed as a low cost, easy to use test, it has already received the necessary FDA approvals. QT 5 is positioned to accept volume orders commencing in February or March. We also plan to focus on our application for Phase III (ease of use) approval by the FDA on our HIV/AIDS 1 & 2 test. mfg Money |
|
| aus der Diskussion: | +++ Wieder positive Meldung - Kurssprung +++ |
| Autor (Datum des Eintrages): | MoneymakerIII (10.01.04 02:21:21) |
| Beitrag: | 7 von 14 (ID:11800763) |
| Alle Angaben ohne Gewähr © wallstreetONLINE | |